시장보고서
상품코드
1941781

수술실 통합(OR 통합) 시장 규모, 점유율, 동향 분석 보고서 : 컴포넌트별, 유형별, 애플리케이션별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Operating Room Integration Market Size, Share & Trends Analysis Report By Component, By Type, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033

발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 110 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

수술실 통합(OR 통합) 시장 요약

세계의 수술실 통합 시장 규모는 2025년에 23억 5,000만 달러로 평가되며, 2033년까지 56억 7,000만 달러에 달할 것으로 예측됩니다.

2026-2033년 연평균 복합 성장률(CAGR) 11.67%로 확대될 것으로 예측됩니다. 이러한 성장은 주로 기술적으로 진보된 용도에 대한 수요 증가, 수술 건수 증가, 수술실(OR) 혼잡, 수술실내 환자 안전에 대한 우려, 최소침습수술(MIS)에 대한 선호도 증가에 기인한 것으로 분석됩니다.

수술실에서의 환자 안전에 대한 관심이 높아지고 있습니다. 통합 시스템은 수술 중 높은 의료 수준을 유지하는 데 필수적인 실시간 데이터 시각화와 구조화된 문서화를 강화합니다. 다양한 출처의 데이터를 단일 플랫폼에 통합함으로써, 이러한 시스템은 오류의 위험을 줄이고 환자의 전체 치료 결과를 개선합니다. 시점 변경의 제한 없이 원격 지원이 가능한 3D 수술실의 개념은 정보통신기술과 확장현실(XR)을 통합한 수술기술의 중요한 발전입니다. 이 혁신적인 접근 방식은 몰입형 시각화 및 원격 협업 툴을 제공함으로써 의료 전문가의 수술 중 역량을 강화합니다.

의료시설내 첨단 IT 솔루션의 통합은 수술 워크플로우의 관리 개선과 업무 효율성 향상을 돕습니다. 클라우드 기반 솔루션과 같은 혁신 기술은 수술실 운영 관리에 유연성과 확장성을 제공하여 시장의 성장을 가속하고 있습니다. 예를 들어 2023년 7월 올림푸스한국은 최신 수술실 시각화 및 통합 솔루션 'EASYSUITE ES-IP 시스템'을 발표했습니다. 이 혁신적인 시스템은 모듈식 및 확장 가능한 접근 방식을 통해 임상 업무의 효율성과 환자 치료 프로세스 개선을 목표로 설계되었습니다.

또한 정부와 민간 기관은 수술실 기술을 포함한 의료 인프라 개선에 투자하고 있습니다. 이러한 자금 조달 구상은 의료시설의 현대화 및 첨단 수술 기술에 대응할 수 있는 통합 수술실 시스템 도입을 지원하는 것을 목표로 하고 있습니다. 2025년 1월, 런던에 본사를 둔 의료기술 스타트업 VitVio가 병원용 인공지능(AI) 탑재 수술실 개발을 위한 프리시드 펀딩으로 205만 달러(한화 약 22억 원)를 조달하는 데 성공했습니다. 이번 자금 조달은 LDV 캐피탈이 주도했으며, 벡벤처스, 타이니 슈퍼컴퓨터 인베스트먼트 컴퍼니(Tiny Supercomputer Investment Company) 및 다수의 엔젤 투자자들이 참여했습니다. 이번 투자는 인공지능이 수술의 효율성과 환자 예후를 개선할 수 있는 가능성에 대한 신뢰가 높아진 것을 반영합니다.

하이브리드 수술실의 보급 확대는 시장 성장을 촉진하는 중요한 요소입니다. 기존 수술법과 최소침습 기술을 결합한 하이브리드 수술실에서는 다양한 장비를 효과적으로 관리할 수 있는 첨단 통합 솔루션이 요구됩니다. 이러한 수술 방법의 진화는 효율성과 환자 치료의 전반적인 질을 향상시키는 것을 목표로 하고 있습니다.

자주 묻는 질문

  • 수술실 통합 시장 규모는 어떻게 예측되나요?
  • 수술실 통합 시장의 성장은 어떤 요인에 기인하나요?
  • 수술실에서 환자 안전을 강화하기 위한 통합 시스템의 역할은 무엇인가요?
  • 하이브리드 수술실의 보급이 시장에 미치는 영향은 무엇인가요?
  • 의료시설 내 첨단 IT 솔루션의 통합이 수술실 운영에 미치는 영향은 무엇인가요?
  • 정부와 민간 기관의 수술실 기술에 대한 투자 현황은 어떤가요?

목차

제1장 조사 방법과 범위

제2장 개요

제3장 수술실 통합 시장 변수, 동향, 범위

제4장 수술실 통합 시장 : 컴포넌트별 추정·동향 분석

제5장 수술실 통합 시장 : 유형별 추정·동향 분석

제6장 수술실 통합 시장 : 애플리케이션별 추정·동향 분석

제7장 수술실 통합 시장 : 최종 용도별 추정·동향 분석

제8장 수술실 통합 시장 : 지역별 추정·동향 분석

제9장 경쟁 구도

KSA 26.03.19

Operating Room Integration Market Summary

The global operating room integration market size was valued at USD 2.35 billion in 2025 and is expected to reach USD 5.67 billion by 2033, expanding at a CAGR of 11.67% from 2026 to 2033. This growth is primarily attributed to the increasing demand for technologically advanced applications, a growing number of surgical procedures, congestion in Operating Rooms (OR), patient safety concerns in OR, coupled with the surge in preference for Minimally Invasive Surgeries (MIS).

There is a growing focus on improving patient safety in operating rooms. Integrated systems enhance real-time data visualization and structured documentation, which are vital for maintaining high standards of care during surgeries. By consolidating information from various sources into a single platform, these systems reduce the risk of errors and improve overall patient outcomes. The concept of a 3D operating room with unlimited perspective change and remote support represents a significant advancement in surgical technology, integrating information and communication technologies with extended reality (XR). This innovative approach enhances the capabilities of medical professionals during surgical procedures by providing immersive visualizations and remote collaboration tools.

The integration of advanced IT solutions within healthcare facilities supports better management of surgical workflows and enhances operational efficiencies. Innovations such as cloud-based solutions provide flexibility and scalability for managing OR operations, further driving market growth. For instance, in July 2023, Olympus Corporation launched its latest procedure room visualization and integration solution, the EASYSUITE ES-IP system. This innovative system is designed to enhance clinical operations and improve patient care pathways through a modular and scalable approach.

Moreover, governments and private organizations are investing in healthcare infrastructure improvements, including operating room technologies. These funding initiatives aim to modernize healthcare facilities and support the adoption of integrated OR systems that can accommodate advanced surgical techniques. In January 2025, VitVio, a London-based healthcare technology startup, successfully raised USD 2.05 million in pre-seed funding aimed at developing artificial intelligence (AI)-powered operating rooms for hospitals. This funding round was led by LDV Capital, with participation from Bek Ventures, Tiny Supercomputer Investment Company, and various angel investors. The investment reflects growing confidence in the potential of artificial intelligence to enhance surgical efficiency and patient outcomes.

The increasing popularity of hybrid operating rooms (ORs) is a significant factor driving the growth of the market. By combining traditional surgical methods with minimally invasive techniques, these hybrid ORs require advanced integration solutions to effectively manage a variety of equipment. This evolution in surgical practices aims to enhance both efficiency and the overall quality of patient care.

Global Operating Room Integration Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global operating room integration market report based on component, type, application, end use, and region:

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
  • Services
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Audio video management systems
  • Display systems
  • Documentation management systems
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • General Surgery
  • Orthopedic Surgery
  • Neurosurgery
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Component Segment
    • 1.2.2. Type Segment
    • 1.2.3. Application Segment
    • 1.2.4. End Use
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Operating room integration Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. Operating room integration Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Social Landscape

Chapter 4. Operating Room Integration Market: Component Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Operating Room Integration Market Component Movement Analysis
  • 4.3. Global Operating Room Integration Market Size & Trend Analysis, by Component, 2021 to 2033 (USD Million)
  • 4.4. Software
    • 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5. Services
    • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Operating Room Integration Market: Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Operating Room Integration Market Type Movement Analysis
  • 5.3. Global Operating Room Integration Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 5.4. Audio video management systems
    • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.5. Display systems
    • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.6. Documentation management systems
    • 5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Operating Room Integration Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Operating Room Integration Market Application Movement Analysis
  • 6.3. Global Operating Room Integration Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. General Surgery
    • 6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5. Orthopedic Surgery
    • 6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. Neurosurgery
    • 6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Operating Room Integration Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Operating Room Integration Market End Use Movement Analysis
  • 7.3. Global Operating Room Integration Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5. Ambulatory Surgical Centers (ASCs)
    • 7.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. Operating Room Integration Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2025 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.4.2. Canada
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.4.3. Mexico
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.2. Germany
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.3. France
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.4. Italy
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.5. Spain
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.6. Norway
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.3. India
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.4. Australia
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.6. Thailand
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.7.2. Argentina
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.8.3. UAE
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.8.4. Kuwait
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Regulatory framework
      • 8.8.4.3. Competitive scenario
      • 8.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2025
  • 9.4. Key Company Market Share Analysis, 2025
  • 9.5. Company Profiles/Listing
    • 9.5.1. Stryker
      • 9.5.1.1. Company overview
      • 9.5.1.2. Financial performance
      • 9.5.1.3. Product benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. Getinge AB
      • 9.5.2.1. Company overview
      • 9.5.2.2. Financial performance
      • 9.5.2.3. Product benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Braiblab AG
      • 9.5.3.1. Company overview
      • 9.5.3.2. Financial performance
      • 9.5.3.3. Product benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Barco
      • 9.5.4.1. Company overview
      • 9.5.4.2. Financial performance
      • 9.5.4.3. Product benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Dragerwerk AG & Co. KGaA
      • 9.5.5.1. Company overview
      • 9.5.5.2. Financial performance
      • 9.5.5.3. Product benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. Steris Plc.
      • 9.5.6.1. Company overview
      • 9.5.6.2. Financial performance
      • 9.5.6.3. Product benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. KARL STORZ SE & CO. KG
      • 9.5.7.1. Company overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Olympus
      • 9.5.8.1. Company overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. Care Syntax
      • 9.5.9.1. Company overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. Arthrex, Inc.
      • 9.5.10.1. Company overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. ALVO Medical
      • 9.5.11.1. Company overview
      • 9.5.11.2. Financial performance
      • 9.5.11.3. Product benchmarking
      • 9.5.11.4. Strategic initiatives
    • 9.5.12. Skytron, LLC
      • 9.5.12.1. Company overview
      • 9.5.12.2. Financial performance
      • 9.5.12.3. Product benchmarking
      • 9.5.12.4. Strategic initiatives
    • 9.5.13. Merivaara
      • 9.5.13.1. Company overview
      • 9.5.13.2. Financial performance
      • 9.5.13.3. Product benchmarking
      • 9.5.13.4. Strategic initiatives
    • 9.5.14. Richard Wolf GmbH
      • 9.5.14.1. Company overview
      • 9.5.14.2. Financial performance
      • 9.5.14.3. Product benchmarking
      • 9.5.14.4. Strategic initiatives
    • 9.5.15. Ditec Medical
      • 9.5.15.1. Company overview
      • 9.5.15.2. Financial performance
      • 9.5.15.3. Product benchmarking
      • 9.5.15.4. Strategic initiatives
    • 9.5.16. Caresyntax
      • 9.5.16.1. Company overview
      • 9.5.16.2. Financial performance
      • 9.5.16.3. Product benchmarking
      • 9.5.16.4. Strategic initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제